Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Establishment Labs Holdings Inc.NASDAQ: ESTA

EPS (Basic) · Q3 FY2026 · quarter ended Sep 2026

EPS (Basic) remains negative

Q3 FY2026 EPS (Basic) was -$0.35, compared with -$0.38 a year earlier. Trailing-twelve-month EPS (Basic) was -$1.28.

Context

  • EPS (Basic) grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 6 analysts of -$1.38 (+19.9%) for the fiscal year ending Dec 2026, a slowdown from the +42.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
-$0.35+10.3% QoQ
Last fiscal yearDec 2025
-$1.72+42.7% YoY
LTMSep 2026
-$1.28+54.8% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.9%-114.1%-122.0 pp
1 year+42.7%+19.9%-22.7 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(1.72) USD
Year-over-year change
+42.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 EPS (Basic) of -$1.28 is the 3rd highest of the 4 companies compared; the peer median is -$0.77.
  • Its year-over-year change of +54.8% is the highest of 4, against a peer median of -41.3%.
ESTA Competitors Peer median
EPS (Basic) for ESTA and competitors
Company Period LTM YoY 3-year CAGR
INMDInMode Ltd.LTM Mar 2026$1.38 -41.3%-9.6%
TELATELA Bio, Inc.LTM Jun 2026-$0.77 +31.2%—
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026-$1.28 +54.8%—
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026-$6.48 -1605.8%—
Peer median (excluding ESTA) -$0.77-41.3%-9.6%

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue126.68M161.7M165.15M166.03M211.08M
Cost of Revenue41.28M55.11M58.17M56.5M64.77M
Gross Profit85.4M106.6M106.98M109.53M146.31M
Gross Margin67.4%65.9%64.8%66.0%69.3%
Research & Development18.32M20.27M26.43M19.71M20.25M
Selling, General & Admin92.23M125.98M145.58M139.81M165.07M
Operating Expenses110.54M146.25M172M159.51M185.32M
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
EBITDA(26.53M)(56.73M)(58.31M)(56.22M)(22.29M)
EBITDA Margin-20.9%-35.1%-35.3%-33.9%-10.6%
Operating Income(25.14M)(39.66M)(65.03M)(49.99M)(39.01M)
Operating Margin-19.8%-24.5%-39.4%-30.1%-18.5%
Interest Income23K87K1.02M1.48M423K
Interest Expense9.06M11.76M15.39M20.83M25.26M
Other Income / Expenses(14.57M)(33.17M)(13.56M)(34.64M)(19.01M)
Income Before Tax(39.71M)(72.82M)(78.58M)(84.63M)(58.02M)
Pre-Tax Margin-31.3%-45.0%-47.6%-51.0%-27.5%
Income Tax Expense1.43M2.39M(81K)(32K)(6.96M)
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Net Margin-32.5%-46.5%-47.5%-51.0%-24.2%
EPS (Basic)(1.72)(3.08)(3.07)(3.00)(1.72)
EPS (Diluted)(1.72)(3.08)(3.07)(3.00)(1.72)
Weighted Avg Shares23.97M24.46M25.6M28.16M29.62M
Weighted Avg Shares (Diluted)23.97M24.46M25.6M28.16M29.62M

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.